Response to Letters re: The COAPT Trial

Affiliations

¹ Baylor Scott & White Heart Hospital Plano, Plano, TX.
² New York Presbyterian Hospital, Columbia University Medical Center, New York, NY; The Cardiovascular Research Foundation, New York, NY.

Comment

Michael J Mack et al. Cardiovasc Revasc Med. 2019 Jun.

. 2019 Jun;20(6):531-532.

doi: 10.1016/j.carrev.2019.04.025.

¹ Baylor Scott & White Heart Hospital Plano, Plano, TX.
² New York Presbyterian Hospital, Columbia University Medical Center, New York, NY; The Cardiovascular Research Foundation, New York, NY.

No abstract available

Comment on

Transcatheter Mitral-Valve Repair in Patients with Heart Failure.
Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ; COAPT Investigators. Stone GW, et al. N Engl J Med. 2018 Dec 13;379(24):2307-2318. doi: 10.1056/NEJMoa1806640. Epub 2018 Sep 23. N Engl J Med. 2018. PMID: 30280640 Clinical Trial.
Reflections on percutaneous therapies for secondary mitral regurgitation.
Goldberg SL. Goldberg SL. Cardiovasc Revasc Med. 2019 Jun;20(6):528-529. doi: 10.1016/j.carrev.2019.02.027. Epub 2019 Mar 15. Cardiovasc Revasc Med. 2019. PMID: 30905660 No abstract available.
Blinding results for transcatheter mitral valve repair.
Khan JM, Musallam A, Waksman R. Khan JM, et al. Cardiovasc Revasc Med. 2019 Jun;20(6):530. doi: 10.1016/j.carrev.2019.03.012. Epub 2019 Mar 19. Cardiovasc Revasc Med. 2019. PMID: 31000434 No abstract available.